Ashwagandha Cultivars and Extracts: KSM-66, Sensoril, Shoden

Ashwagandha (Withania somnifera) is the most clinically validated herbal adaptogen for stress and anxiety. The body of evidence, Pratte 2014 meta-analysis, Chandrasekhar 2012, Salve 2019, Lopresti 2019, supports cortisol reduction, anxiety relief, sleep improvement, and modest testosterone support in men. What gets less attention is that essentially all this clinical evidence uses three specific branded extracts: KSM-66, Sensoril, and Shoden. Generic ashwagandha is not what the literature studied.

Why standardisation matters

Withania somnifera contains roughly 60 withanolides (the main bioactive class) plus alkaloids and amino acids. The proportion of each varies dramatically depending on which part of the plant is extracted (root, leaf, or whole plant), what solvent system is used, what cultivar of W. somnifera the plant came from, and where it was grown.

Two unstandardised ashwagandha products can have a 10x difference in withanolide content while looking identical on the label. This is why the branded extracts dominate the literature, they provide reproducible bioactive content, which is the minimum requirement for clinical trials. Generic ashwagandha may or may not work depending on the source material.

KSM-66

KSM-66 is the most-published ashwagandha extract. Ixoreal Biomed developed and patented it. It's a full-spectrum root extract standardised to 5% withanolides, using only roots (no leaf material) and a milk-and-water extraction process that takes 14 days.

The evidence base is substantial, over 25 published human trials covering anxiety, sleep, cortisol, testosterone, athletic performance, and cognitive function. Chandrasekhar 2012 was the foundational chronic stress trial; Salve 2019 confirmed cortisol reduction at 600 mg/day over 60 days; Lopresti 2019 demonstrated testosterone increase in stressed men.

The typical dose across these trials is 300-600 mg per day, most often split AM/PM, taken with meals. The KSM-66 form is widely available, it's the form in Mind Lab Pro, several Onnit products, Examine's recommendations, and most premium supplement brands.

Best for: comprehensive stress management, cortisol reduction, sleep support, testosterone support in men, athletic performance.

Sensoril

Sensoril is the older competing patented extract, Natreon developed and licensed it. It uses both root and leaf material and is standardised to a much higher 8-10% withanolide content. The total withanolide delivery per mg of compound is therefore higher than KSM-66.

The evidence base is smaller but consistent. Auddy 2008 demonstrated stress and anxiety reduction at 250 mg/day. Choudhary 2017 showed cognitive function improvement in healthy adults. The higher withanolide content per mg means lower doses are clinically effective, typical dose is 125-250 mg per day.

The trade-off: the leaf material in Sensoril introduces some withaferin A, a withanolide with mild cytotoxic properties at high concentrations. The clinical safety of Sensoril is established at the labelled doses, but the cytotoxicity concern means users should not megadose.

Best for: lower-dose protocols, users who specifically want the higher withanolide-per-mg ratio, evening dosing for sleep (some users find Sensoril more sedating than KSM-66).

Shoden

Shoden is the newest of the three branded extracts. Arjuna Natural developed it. It's standardised to 35% withanolide glycosides, the highest concentration of any commercial ashwagandha, using a proprietary water-based extraction.

The evidence base is small but growing. Langade 2019 demonstrated sleep quality improvement at 120 mg/day; subsequent trials show effects at this very low dose. The high concentration means clinically effective doses are 60-120 mg per day, substantially lower than KSM-66 or Sensoril.

The low dose is the value proposition. Users who take many supplements may prefer Shoden for capsule size reasons. The longer-term evidence base is still building, so KSM-66 retains the strongest evidence-volume position.

Best for: low-dose protocols, evening sleep dosing, users prioritising minimal capsule volume.

Generic ashwagandha

Unstandardised whole-root ashwagandha powder ranges in withanolide content from approximately 0.5% to 3%, with substantial variation between manufacturers. Some generic products from reputable mushroom-and-herb suppliers (Nootropics Depot, Banyan Botanicals) provide reasonable bioactive content at lower cost. Other generic products provide essentially decorative quantities of withanolides.

The practical problem is that generic ashwagandha labels rarely disclose withanolide content. Without that disclosure, you cannot calculate dose accuracy versus the clinical literature.

Two reasonable approaches for users who prefer generic: choose a brand that publishes Certificates of Analysis showing withanolide percentage, then calculate dose to match clinical literature (typically aiming for 5-30 mg withanolides per day). Or, just buy KSM-66, the dose calculation is done for you and the published evidence applies.

Practical selection

If you have a specific outcome in mind, match the extract to the trial that demonstrates that outcome:

For chronic stress and cortisol reduction: KSM-66 600 mg/day, split AM/PM. Salve 2019 trial.

For anxiety: KSM-66 300 mg twice daily. Multiple Pratte 2014 trials.

For sleep specifically: Shoden 120 mg in the evening, or KSM-66 300 mg with dinner. Langade 2019; Salve 2019 sleep arm.

For athletic performance / testosterone support in men: KSM-66 600 mg/day. Lopresti 2019; Wankhede 2015.

For cognitive function in healthy adults: KSM-66 600 mg/day or Sensoril 250 mg/day. Choudhary 2017.

For users on a tight budget who want generic: choose a brand publishing withanolide percentages, target 5-10 mg withanolides per day for low-intensity use or 15-30 mg withanolides per day for clinical-equivalent dosing.

Cycling

Most published ashwagandha trials run 30-90 days continuously. Long-term tolerability appears excellent, multi-year use in traditional Ayurvedic medicine is well-tolerated. Whether adaptogen response declines with sustained use is debated; some users report waning effects after several months and benefit from a 1-2 week wash-out.

A reasonable cycling protocol: continuous daily use for 90 days, then a 1-week wash-out, then continue. Users who experience the calming effect strongly may prefer a more aggressive cycle (4 weeks on, 1 week off).

Who shouldn't take it

Pregnancy and breastfeeding, emerging concerns about oxytocin signalling and lactation. Hyperthyroidism, ashwagandha can mildly stimulate thyroid hormone production, which is desirable in hypothyroid users but contraindicated in hyperthyroid. Autoimmune thyroid conditions, Hashimoto's users should coordinate with their endocrinologist. Active sedative or anxiolytic medication, additive effects can produce excessive sedation.

The general safety profile is excellent for healthy adults at clinical doses. The above contraindications are exceptions to that pattern, not the rule.